Current Report Filing (8-k)
January 29 2021 - 4:01PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of report (Date of earliest event reported): January 29, 2021 (January 27, 2021)
Celsion
Corporation
(Exact
Name of Registrant as Specified in Charter)
Delaware
|
|
001-15911
|
|
52-1256615
|
(State
or Other Jurisdiction
of
Incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
997
Lenox Drive, Suite 100, Lawrenceville, NJ 08648
(Address
of Principal Executive Offices, and Zip Code)
(609)
896-9100
Registrant’s
Telephone Number, Including Area Code
N/A
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
|
[ ]
|
Written
communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
[ ]
|
Pre-commencement
communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
[ ]
|
Pre-commencement
communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Common
stock, par value $0.01 per share
|
|
CLSN
|
|
Nasdaq
Capital Market
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
On January 27, 2021,
Celsion Corporation, a Delaware Corporation (the “Company”), received
a notice from the Nasdaq Listing Qualifications department. The notice stated that, as a result of Dr. Alberto Martinez’s
resignation on December 31, 2020, the Company is no longer in compliance with Nasdaq’s audit committee requirement under
Listing Rule 5605 to maintain a committee of at least three independent members. On December 28, 2020, Dr. Alberto Martinez, a
Class II member of the Board of Directors (the “Board”) of the Company announced that he has decided to retire
from the Company’s Board of Directors effective December 31, 2020. Dr. Martinez was a member of the Audit and Compensation
Committees of the Board. Upon reaching the age of 71, Dr. Martinez’s decision to retire from the Board was for personal
reasons and not because of any disagreement with management or the Board relating to the Company’s operations, policies
or practices. Dr. Martinez’s current term as a Class II director was scheduled to end at the Company’s 2021
Annual Meeting of Stockholders.
In
accordance with Nasdaq Listing Rule 5605(c)(4), Nasdaq has provided the Company with the following cure period to regain compliance:
|
●
|
until
the earlier of the Company’s next annual shareholders’ meeting or December 31, 2021; or
|
|
●
|
if
the next annual shareholders’ meeting is held before June 29, 2021, then the Company must evidence compliance no later
than June 29, 2021.
|
Dr.
Donald Braun, an independent member of the Company’s Board, has agreed to serve on the Audit Committee to fill the vacancy
created by Dr. Martinez’s retirement. Dr. Braun’s appointment will satisfy the applicable requirements of the Nasdaq
Listing Rules and will be ratified by the Board at their next regularly scheduled Board meeting in March 2021.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
CELSION
CORPORATION
|
|
|
|
Date:
January 29, 2021
|
By:
|
/s/
Jeffrey W. Church
|
|
|
Jeffrey
W. Church
|
|
|
Executive
Vice President and
Chief Financial Officer
|
Celsion (NASDAQ:CLSN)
Historical Stock Chart
From Apr 2024 to May 2024
Celsion (NASDAQ:CLSN)
Historical Stock Chart
From May 2023 to May 2024